Clinical Trials Sponsored by Center for Research to Practice

Total 4876 results

Swiss Group for Clinical Cancer Research

Completed

Trastuzumab & Pertuzumab Followed by T-DM1 in MBC

Metastatic Breast Cancer

France, Switzerland, Netherlands, Germany
Swiss Group for Clinical Cancer Research

Terminated

Bevacizumab in Treating Patients Who Have Undergone First-Line Therapy for Metastatic Colorectal Cancer

Colorectal Cancer

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Vinorelbine in Treating Patients With Metastatic Prostate Cancer

Prostate Cancer

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Fulvestrant With or Without AZD6244 in Treating Patients With Advanced Breast Cancer That Progressed After Aromatase Inhibitor Therapy

Breast Cancer

Switzerland, Belgium
Swiss Group for Clinical Cancer Research

Completed

Bevacizumab and Erlotinib Followed by Cisplatin or Carboplatin and Gemcitabine in Treating Patients With Newly Diagnosed or Recurrent Stage IIIB or Stage IV NSCLC

Lung Cancer

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Orteronel Maintenance Therapy in Patients With Metastatic Castration Resistant Prostate Cancer and Non-progressive Disease After First-line Docetaxel Therapy

Prostate Cancer

Switzerland
International Agency for Research on Cancer

Completed

Biomarkers of Processed Meat Intake

Biomarkers of Processed Meat Intake in Healthy Subjects

France
Swiss Group for Clinical Cancer Research

Terminated

Cetuximab for Elderly Patients With mCRC

Metastatic Colorectal Cancer

Switzerland
Swiss Group for Clinical Cancer Research

Terminated

Transarterial Chemoembolization With Doxorubicin With or Without Everolimus in Treating Patients With Liver Cancer

Liver Cancer

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Capecitabine and Radiation Therapy With or Without Panitumumab in Treating Patients With Advanced Rectal Cancer

Colorectal Cancer

Switzerland, Hungary
Swiss Group for Clinical Cancer Research

Completed

Azacitidine in Treating Patients With Newly Diagnosed Previously Untreated or Secondary Acute Myeloid Leukemia Who Are Unsuitable For Intensive Chemotherapy

Leukemia

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Radiation Therapy Combined With Either Gefitinib or Temozolomide in Pats With NSCLC and Brain Metastases

Lung Cancer | Metastatic Cancer

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Capecitabine and Oxaliplatin With or Without Cetuximab in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery

Colorectal Cancer

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma

Lymphoma

Italy, Switzerland, Austria, Germany, Greece
Swiss Group for Clinical Cancer Research

Completed

Rituximab in Treating Patients With Refractory or Recurrent Hairy Cell Leukemia Following Cladribine Therapy

Leukemia

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Daily or Weekly Cladribine in Treating Patients With Hairy Cell Leukemia

Leukemia

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Paclitaxel in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia

Leukemia

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Combination Chemotherapy in Treating Patients With Advanced or Metastatic Colorectal Cancer

Colorectal Cancer

Switzerland
NICHD Neonatal Research Network
National Center for Research Resources (NCRR)

Completed

Trial of Aggressive Versus Conservative Phototherapy in Infants <1,000 Grams Birth Weight (Phototherapy)

Hyperbilirubinemia, Neonatal | Jaundice, Neonatal | Infant, Small for Gestational Age | Infant, Premature | Infant, Low Birth Weight | Infant, Newborn

United States
NICHD Neonatal Research Network
National Center for Research Resources (NCRR)

Completed

Dexamethasone Therapy in VLBW Infants at Risk of CLD (Dexamethasone)

Bronchopulmonary Dysplasia | Infant, Small for Gestational Age | Infant, Premature | Infant, Low Birth Weight | Infant, Newborn

United States
NICHD Neonatal Research Network
National Center for Research Resources (NCRR)

Completed

In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight Infants (MgSO4)

Cerebral Palsy | Intracranial Hemorrhages | Infant, Small for Gestational Age | Infant, Premature | Leukomalacia, Periventricular | Infant, Low Birth Weight | Infant, Newborn

United States
NICHD Neonatal Research Network
National Center for Research Resources (NCRR)

Terminated

Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure (Preemie iNO)

Pneumonia | Sepsis | Hypertension, Pulmonary | Infant, Small for Gestational Age | Infant, Premature | Infant, Low Birth Weight | Infant, Newborn | Respiratory Distress Syndrome (RDS)

United States
NICHD Neonatal Research Network
National Center for Research Resources (NCRR)

Completed

Development of Standards for the New Ballard Maturation Score (Ballard)

Pregnancy | Infant, Small for Gestational Age | Infant, Premature | Infant, Low Birth Weight | Infant, Newborn

United States
NICHD Neonatal Research Network
National Center for Research Resources (NCRR)

Completed

Benchmarking Initiative to Reduce Bronchopulmonary Dysplasia (Benchmarking)

Bronchopulmonary Dysplasia (BPD) | Infant, Small for Gestational Age | Infant, Premature | Infant, Low Birth Weight | Infant, Newborn

United States
NICHD Neonatal Research Network
National Center for Research Resources (NCRR)

Completed

Antenatal Phenobarbital to Prevent Neonatal Intracranial Hemorrhage (Phenobarbital)

Intracranial Hemorrhages | Infant, Small for Gestational Age | Infant, Premature | Infant, Low Birth Weight | Infant, Newborn

United States
NICHD Neonatal Research Network
National Center for Research Resources (NCRR)

Completed

Whole-Body Cooling for Birth Asphyxia in Term Infants

Hypoxia-Ischemia, Brain | Infant, Newborn

United States
NICHD Neonatal Research Network
National Center for Research Resources (NCRR)

Completed

Persistent Pulmonary Hypertension of the Newborn (PPHN) Observational Study (PPHN)

Persistent Fetal Circulation Syndrome | Infant, Small for Gestational Age | Persistent Pulmonary Hypertension of Newborn | Infant, Premature | Infant, Low Birth Weight | Infant, Newborn

United States
NICHD Neonatal Research Network
National Center for Research Resources (NCRR)

Completed

Delayed Cord Clamping in VLBW Infants

Infant, Small for Gestational Age | Infant, Premature | Infant, Low Birth Weight | Infant, Newborn

United States
NICHD Neonatal Research Network
National Center for Research Resources (NCRR)

Completed

The Effects of Erythropoietin (EPO) on the Transfusion Requirements of Very Low Birth Weight Infants (EPO)

Anemia, Neonatal | Infant, Small for Gestational Age | Infant, Premature | Infant, Low Birth Weight | Infant, Newborn

United States
NICHD Neonatal Research Network
National Center for Research Resources (NCRR)

Completed

Glutamine Supplementation to Prevent Death or Infection in Extremely Premature Infants (Glutamine)

Sepsis | Infant, Small for Gestational Age | Infant, Premature | Infant, Low Birth Weight | Infant, Newborn

United States
NICHD Neonatal Research Network
National Center for Research Resources (NCRR)

Terminated

Minimal Breathing Support and Early Steroids to Prevent Chronic Lung Disease in Extremely Premature Infants (SAVE) (SAVE)

Respiratory Distress Syndrome | Bronchopulmonary Dysplasia | Infant, Small for Gestational Age | Infant, Premature | Infant, Low Birth Weight | Infant, Newborn

United States
NICHD Neonatal Research Network
National Center for Research Resources (NCRR)

Completed

Growth Observational Study (Growth)

Infant, Small for Gestational Age | Infant, Premature | Infant, Low Birth Weight | Infant, Newborn

United States
National Center for Research Resources (NCRR)
Juvenile Diabetes Research Foundation

Unknown

hOKT3gamma1 (Ala-Ala) for the Prevention of Human Islet Allograft Failure

Islets of Langerhans Transplantation | Diabetes Mellitus, Insulin-Dependent | Diabetes Mellitus, Experimental | Transplantation, Homologous

United States
National Center for Research Resources (NCRR)
Juvenile Diabetes Research Foundation

Unknown

Modification of the "Edmonton Protocol" to Allow for Successful Islet Transplantation From a Single Pancreas and Extension of the "Edmonton Protocol" to Kidney Transplant Recipients

Diabetes Mellitus

United States
National Center for Research Resources (NCRR)
Juvenile Diabetes Research Foundation

Unknown

Patterns and Natural History of Insulin Secretion in Islet Cell Transplant Recipients and Controls

Diabetes Mellitus

United States
Piedmont Cancer Institute
Cancer Research UK; Stand Up To Cancer; Lustgarten Foundation; Destroy Pancreatic... and other collaborators

Withdrawn

High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer

Metastatic Pancreatic Cancer

United States
Swiss Group for Clinical Cancer Research

Not yet recruiting

Intratumoral INT230-6 Followed by Neoadjuvant Immuno-chemotherapy in Patients With Early TNBC. INVINCIBLE-4-SAKK

Triple-negative Breast Cancer | TNBC - Triple-Negative Breast Cancer

Switzerland
Swiss Group for Clinical Cancer Research

Recruiting

LIBERTY: Liquid Biopsy to Diagnose and Monitor CNS Involvement in High-risk B Cell Non-Hodgkin Lymphoma (SAKK 38/23)

Non-hodgkin Lymphoma, B Cell

Switzerland
Swiss Group for Clinical Cancer Research

Active, not recruiting

Ibrutinib lead-in Followed by Venetoclax Plus Ibrutinib in Patients With RR CLL

Leukemia | Chronic Lymphocytic Leukemia | Relapsed/Refractory Chronic Lymphocytic Leukemia

Switzerland
Swiss Group for Clinical Cancer Research

Terminated

ODM-201 Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal Agents.

Prostate Cancer | Prostate Cancer Metastatic

France, Switzerland, Spain, Italy
Swiss Group for Clinical Cancer Research

Completed

Preoperative Chemoradiotherapy vs. Chemotherapy Alone in NSCLC Patients

Lung Cancer

Germany, Serbia, Switzerland
Swiss Group for Clinical Cancer Research

Active, not recruiting

1st Line Durvalumab in PS 2 NSCLC Patients

NSCLC Stage IV | NSCLC Stage IIIB

Switzerland
Duke University
Gateway for Cancer Research

Active, not recruiting

Preoperative Single-Fraction Radiotherapy in Early Stage Breast Cancer

Breast Cancer

United States
Swiss Group for Clinical Cancer Research

Active, not recruiting

Thoracic Radiotherapy Plus Maintenance Durvalumab After First Line Carboplatin and Etoposide Plus Durvalumab in Extensive-stage Disease Small Cell Lung Cancer (ED-SCLC).

Small Cell Lung Cancer | Lung Cancer

Switzerland
Swiss Group for Clinical Cancer Research

Active, not recruiting

Neoadjuvant and Adjuvant Durvalumab in Combination With Neoadjuvant Chemotherapy in Patients With Operable Urothelial Cancer. (SAKK 06/17)

Urothelial Cancer

Germany, Switzerland
Swiss Group for Clinical Cancer Research

Terminated

Rogaratinib in Patients With Advanced Pretreated Squamous-cell Non-small Cell Lung Cancer (SQCLC)

Squamous-cell Non-small Cell Lung Cancer

Switzerland
Ludwig Institute for Cancer Research
Medarex

Terminated

A Study of Anti-CTLA-4 Antibody in Patients With Advanced Synovial Sarcoma

Synovial Sarcoma

United States
Swiss Group for Clinical Cancer Research

Terminated

Eribulin as 1st Line Treatment in Elderly Patients With Advanced Breast Cancer

Adenocarcinoma | Breast Cancer

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Binimetinib in Addition to Standard Chemotherapy in KRAS Mutated NSCLC.

Lung Cancer | KRAS Gene Mutation | Advanced Non-small Cell Lung Cancer

Switzerland
Swiss Group for Clinical Cancer Research

Terminated

Alternate Day Dosing of Pomalidomide in Patients With Refractory Multiple Myeloma (OptiPOM)

Refractory Multiple Myeloma

Switzerland

Clinical Trials Sponsored by Center for Research to Practice

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belgium

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations